Literature DB >> 6245177

The prevalence of naturally occurring antibodies to human syncytial virus in East African populations.

H K Muller, G Ball, M A Epstein, B G Achong, G Lenoir, A Levin.   

Abstract

A seroepidemiological study of naturally occurring antibodies to the human syncytial virus has been carried out by means of an indirect immunofluorescence test on 639 East Africans, consisting of 493 normal Ugandans, 66 Kenyan patients with nasopharyngeal carcinoma (NPC), and 80 Kenyan and Tanzanian patients with various other tumours or non-cancerous conditions. It was found that 3.4% of the normal individuals had antibodies to the virus and serial serum samples were available from 14 of these, permitting the study of antibody class in seroconversion and antibody persistence. As in an earlier survey, a significantly higher incidence of antibodies was found amongst NPC patients. Blocking and indirect immunofluorescence test with simian foamy viruses (SFV) showed some cross-reactivity between SFV 6 and the human syncytial virus, but not identity. The results are discussed in relation to the very real occurrence of natural infection by human syncytial virus in certain geographical regions.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245177     DOI: 10.1099/0022-1317-47-2-399

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  11 in total

1.  Human foamy virus bel1 sequence in patients with autoimmune rheumatic diseases.

Authors:  Kuang-Hui Sun; Hsiao-Yi Lin; Lee-Wen Chen; Hsiao-Yun Tai; Mei-Lin Lin; Chi-Kuang Feng; Jung-Sung Sung; Hsin-Fu Liu; Wu-Tse Liu
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

2.  Increase in the basal transcriptional activity of the human foamy virus internal promoter by the homologous long terminal repeat promoter in cis.

Authors:  M Löchelt; M Aboud; R M Flügel
Journal:  Nucleic Acids Res       Date:  1993-09-11       Impact factor: 16.971

Review 3.  Historical perspective of foamy virus epidemiology and infection.

Authors:  C D Meiering; M L Linial
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

4.  Infectious DNA of the human spumaretrovirus.

Authors:  A Rethwilm; G Baunach; K O Netzer; B Maurer; B Borisch; V ter Meulen
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

5.  Isolation of a new foamy retrovirus from orangutans.

Authors:  M O McClure; P D Bieniasz; T F Schulz; I L Chrystie; G Simpson; A Aguzzi; J G Hoad; A Cunningham; J Kirkwood; R A Weiss
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells.

Authors:  D Neumann-Haefelin; A Rethwilm; G Bauer; F Gudat; H zur Hausen
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402

7.  Human foamy virus proteins accumulate in neurons and induce multinucleated giant cells in the brain of transgenic mice.

Authors:  A Aguzzi; E F Wagner; K O Netzer; K Bothe; I Anhauser; A Rethwilm
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

8.  The human foamy virus internal promoter directs the expression of the functional Bel 1 transactivator and Bet protein early after infection.

Authors:  M Löchelt; R M Flügel; M Aboud
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus.

Authors:  B Maurer; H Bannert; G Darai; R M Flügel
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

10.  Human spumavirus antibodies in sera from African patients.

Authors:  C Mahnke; P Kashaiya; J Rössler; H Bannert; A Levin; W A Blattner; M Dietrich; J Luande; M Löchelt; A E Friedman-Kien
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.